The pursuit of smoother, healthier skin continues to drive innovation in aesthetic treatments. Thermo-Mechanical Fractional Injury (TMFI) therapy, delivered via the Tixel® device, is emerging as a promising, low-risk alternative to traditional lasers. Backed by clinical evidence, TMFI offers skin rejuvenation benefits with minimal discomfort and downtime — particularly appealing to those with skin types II to V. This blog explores how TMFI therapy works, its clinical outcomes, and why it could be a breakthrough for safer, more inclusive skin treatments.
TMFI (Thermo-Mechanical Fractional Injury) therapy uses the Tixel® device to deliver controlled heat energy to the skin without lasers or invasive procedures.
Key points:
Non-ablative, fractional treatment: Uses a heated titanium tip to create micro-injuries that stimulate collagen production.
Minimally invasive: No mechanical penetration of the skin.
Suitable for skin types II to V, including those typically more prone to pigmentation issues.
Clinical Study Facial Skin Rejuvenation with Thermo-Mechanical Therapy.pdf
To view the PDF please click here.
Clinical Study Highlights
A retrospective double-centred chart review evaluated TMFI therapy’s effectiveness:
24 patients (ages 39-69) from the UK and Israel.
Skin types II to V included.
Patients received 2 to 3 treatments, spaced 3-5 weeks apart.
Key findings:
Significant improvement in skin complexion and periorbital wrinkles.
Other improvements in skin vitality, pigmentation, pore size, and laxity.
Minimal downtime: Average of 1.7 days.
High patient satisfaction rates for both experience and outcomes.
TMFI therapy with Tixel® presents several patient-friendly benefits:
Less pain during the procedure.
Lower risk of complications compared to traditional laser resurfacing.
Short recovery period with rapid return to social activities.
Effective for darker skin types where laser treatments may pose a higher risk of pigmentation issues.
The study identified practical tips to maximise results:
Adjust settings for different facial areas: Bony areas require lower protrusion settings; softer areas need higher settings.
Consider multiple passes and surface debridement between sessions for deeper skin impact.
Explore TMFI-assisted drug delivery: Combining TMFI with targeted skincare may further enhance outcomes.
Conclusion
TMFI therapy using Tixel® is a safe and effective solution for facial skin rejuvenation across a wide range of skin types. With minimal downtime and proven improvements in skin texture and vitality, it offers a promising alternative to more invasive procedures.
Ready to explore the future of skin rejuvenation?
Contact us today to find out how TMFI therapy can support your aesthetic goals.
If you’ve been struggling with persistent rosacea redness and flushing, the combination of Tixel and botulinum toxin could be the innovative solution you’ve been waiting for. This approach targets the problem at its source, offering not just temporary relief, but a significant improvement in skin health and confidence.
Arrange an in-clinic demonstration to explore how Tixel® can support your clinical outcomes